Registry-listed formulations

cefditoren pivoxil · mesh:C057710

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

4 source entries across 4 studies. This list may not include all unresolved or historical entries.

  • cefditoren pivoxilRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Cefditoren pivoxil 400mgRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • MEIACT 200 mg comprimidos recubiertos con películaRegistry product

    Molecular identity unconfirmed

    Formulation reported by source: FILM-COATED TABLET

    Named ingredient; exact form unconfirmed. This mention does not add to the molecule trial count.

    View study and source
  • cefditoren pivoxil tabletsRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Phase 3
1
25%
Phase 4
2
50%
Not Applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (25.0%)
Phase 42 (50.0%)
N/A1 (25.0%)

Trials by Status

completed375%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Pharmacokinetic Study of Cefditoren Pivoxil in Breast Milk and Blood of Lactating Women

NCT06644105
completedphase_4

Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia

NCT04709172
unknownphase_4

Study of Cefditoren Pivoxil in Treatment of Childhood With Acute Rhinosinusitis

NCT01553006
completedphase_3

Efficacy and Safety of Cefditoren Pivoxil Versus Ciprofloxacin in Acute Uncomplicated Cystitis

NCT00598403

Clinical Trials (4)

Showing 4 of 4 trials
NCT06644105Not Applicable

Pharmacokinetic Study of Cefditoren Pivoxil in Breast Milk and Blood of Lactating Women

Completed
NCT04709172Phase 4

Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia

Completed
NCT01553006Phase 4

Study of Cefditoren Pivoxil in Treatment of Childhood With Acute Rhinosinusitis

Unknown
NCT00598403Phase 3

Efficacy and Safety of Cefditoren Pivoxil Versus Ciprofloxacin in Acute Uncomplicated Cystitis

Completed

All 4 trials loaded

Drug Details

Intervention Type
Drug
Molecule Type
Small molecule
Total Trials
4

External References

ChEMBL
CHEMBL454446

Names & Codes

Trade Names

Spectracef

Research Codes

ME 1207NSC-759098